SelectQuote (SLQT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for November 11, 2025, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by November 10, 2025.
Voting matters and shareholder proposals
Election of two Class III director nominees, Donald L. Hawks III and Denise L. Devine, for three-year terms.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending June 30, 2026.
Advisory vote on executive compensation for named executive officers.
Proxy holders authorized to vote on other business arising at the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from SelectQuote
- Diversified insurance and healthcare platform achieves strong growth and operational efficiency.SLQT
Investor presentation - Q3 FY2026 revenue up 6% to $430.9M, net income $40.2M, with robust segment growth and outlook.SLQT
Q3 2026 - Revenue up 12% to $537.1M, net income $69.3M, and guidance cut by $40M amid external headwinds.SLQT
Q2 2026 - Board recommends approval of all 2025 meeting proposals, emphasizing performance and governance.SLQT
Proxy Filing - Board recommends approval of all proposals, highlighting governance and pay-for-performance.SLQT
Proxy Filing - All proposals passed, including director elections and auditor ratification, with no shareholder questions.SLQT
AGM 2025 - FY2024 results surpassed expectations, with robust growth in revenue and profitability.SLQT
Q4 2024 - Revenue up 26% with strong pharmacy growth; $100M securitization boosts capital flexibility.SLQT
Q1 2025 - Q2 revenue up 19% to $481.1M, net income $53.2M, $350M equity investment secured.SLQT
Q2 2025